| Southern Pines Health And Rehab | |
| 700 Manor Rd, Prescott, Arkansas 71857 | |
| (870) 455-1086 | |
| Name | Southern Pines Health And Rehab |
|---|---|
| Location | 700 Manor Rd, Prescott, Arkansas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 111 |
| Occupancy Rate | 38.2% |
| Medicare ID (CCN) | 045470 |
| Legal Business Name | Prescott Snf Operations, Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1003438789 |
| Organization Name | PRESCOTT SNF OPERATIONS, LLC |
| Address | 700 Manor Rd, Prescott, AR 71857 |
| Phone Number | 870-455-1086 |
News Archive
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.
Public health and safety would benefit from eliminating daylight saving time, according to a position statement from the American Academy of Sleep Medicine.
Genetic manipulation that more than doubles lifespan also leads to better offspring - according to new collaborative research from the University of East Anglia and Uppsala University.
Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become drug resistant, according to research published in Cancer Research today.
› Verified 8 days ago
| NPI Number | 1215676903 |
| Organization Name | SOUTHERN PINES HEALTH OPCO LLC |
| Doing Business As | SOUTHERN PINES HEALTH AND REHAB |
| Address | 700 Manor Rd, Prescott, AR 71857 |
| Phone Number | 870-455-1086 |
News Archive
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.
Public health and safety would benefit from eliminating daylight saving time, according to a position statement from the American Academy of Sleep Medicine.
Genetic manipulation that more than doubles lifespan also leads to better offspring - according to new collaborative research from the University of East Anglia and Uppsala University.
Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become drug resistant, according to research published in Cancer Research today.
› Verified 8 days ago
| NPI Number | 1508491465 |
| Organization Name | PRESCOTT OPS, LLC |
| Address | 700 Manor Rd, Prescott, AR 71857 |
| Phone Number | 870-455-1086 |
News Archive
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.
Public health and safety would benefit from eliminating daylight saving time, according to a position statement from the American Academy of Sleep Medicine.
Genetic manipulation that more than doubles lifespan also leads to better offspring - according to new collaborative research from the University of East Anglia and Uppsala University.
Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become drug resistant, according to research published in Cancer Research today.
› Verified 8 days ago
| NPI Number | 1841833258 |
| Organization Name | VBNC OPS, INC. |
| Address | 700 Manor Rd, Prescott, AR 71857 |
| Phone Number | 870-455-1086 |
News Archive
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.
Public health and safety would benefit from eliminating daylight saving time, according to a position statement from the American Academy of Sleep Medicine.
Genetic manipulation that more than doubles lifespan also leads to better offspring - according to new collaborative research from the University of East Anglia and Uppsala University.
Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become drug resistant, according to research published in Cancer Research today.
› Verified 8 days ago
| NPI Number | 1871500983 |
| Organization Name | KSJ, LLC |
| Doing Business As | PRESCOTT MANOR NURSING CENTER |
| Address | 700 Manor Rd, Prescott, AR 71857 |
| Phone Number | 870-887-6639 |
News Archive
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.
Public health and safety would benefit from eliminating daylight saving time, according to a position statement from the American Academy of Sleep Medicine.
Genetic manipulation that more than doubles lifespan also leads to better offspring - according to new collaborative research from the University of East Anglia and Uppsala University.
Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become drug resistant, according to research published in Cancer Research today.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.
Public health and safety would benefit from eliminating daylight saving time, according to a position statement from the American Academy of Sleep Medicine.
Genetic manipulation that more than doubles lifespan also leads to better offspring - according to new collaborative research from the University of East Anglia and Uppsala University.
Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become drug resistant, according to research published in Cancer Research today.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 17.35 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 12.38 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 10 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.96 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.69 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.79 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.59 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 25.76 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 86.54 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.33 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 14.08 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 34.51 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.56 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |